Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LifeStance Health Gr Q4 Sales $280.60M Beat $263.00M Estimate, Net Loss Of $(45)M Versus Loss Of $(46.7)M A Year Ago

Author: Benzinga Newsdesk | February 28, 2024 07:02am
LifeStance Health Gr (NASDAQ:LFST) reported quarterly sales of $280.60 million which beat the analyst consensus estimate of $263.00 million by 6.69 percent. This is a 22.34 percent increase over sales of $229.36 million the same period last year.

Posted In: LFST


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist